Equitec Proprietary Markets, LLC Abb Vie Inc. Put Options Transaction History

Equitec Proprietary Markets, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $6.43 Million - $7.97 Million	-48,700 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $5.51 Million - $6.14 Million	-52,400 Reduced 51.83%	48,700 $5.49 Million
Q4 2020 Jan 26, 2021	SELL	$80.49 - $108.67 $482,939 - $652,020	-6,000 Reduced 5.6%	101,100 $10.8 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $5.02 Million - $5.89 Million	58,400 Added 119.92%	107,100 $9.38 Million
Q1 2020 Apr 19, 2021	BUY	$64.5 - $97.79 $3.14 Million - $4.76 Million	48,700 New	48,700 $0

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.